Polat et al. have treated MCF-7 cancer cells with an anti-Her2 monoclonal antibody conjugated to the surface of Au NPs (nanospheres, nanorods, and nanocages) followed by UV-Vis spectroscopy and dark-field microscopy analysis of cellular uptake and bioimaging efficiency [83]. Here, ERBB2 is linked to cancer.